Top

BMC Public Health

Published in:

Open Access 01-12-2015 | Research article

The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety

Authors: Laure Fonteneau, Marine Ragot, Isabelle Parent du Châtelet, Jean-Paul Guthmann, Daniel Lévy-Bruhl

Published in: BMC Public Health | Issue 1/2015

Abstract

Background

Since 2011 public concerns about Human Papillomavirus (HPV) vaccination safety and efficacy arose in France. We explored the relevance of using vaccines reimbursement data to assess the impact of those public concerns on vaccination coverage.

Methods

We used the Permanent Sample of Beneficiaries which was, at the time of the study, a representative sample of 1/97^th health insurance beneficiaries of the main Social Security scheme, the General Health Insurance Scheme, covering approximately 77 % of the French resident population. We estimated HPV vaccination coverage among girls born between 1995 and 1999 at their 15^th, 16^th and 17^th birthday.

Results

The coverage for complete vaccination among 16 years old girls decreased from 26.5 % in the first semester of 2011 to 18.6 % in the first semester of 2014.

Conclusions

HPV vaccination coverage was already low in 2011 and continued to decrease thereafter. Vaccines reimbursement data allowed us to reactively monitor the impact of the controversy on vaccination coverage and design counteracting measures.

Woronoff AS, Trétarre B, Guizard AV, Arveux P. Colde l’utérus. In: Binder-Foucard F, Belot A, Delafosse P, Remontet L, Woronoff AS, Bossard N, editors. National estimate of the incidence and mortality from cancer in France between 1980 and 2012 - A study based on Francim network of cancer registries - Part 1 – Solid Tumors. Saint-Maurice: Institut de veille sanitaire; 2013. p. 122. Available online: http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-chroniques-et-traumatismes/2013/Estimation-nationale-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-entre-1980-et-2012. Accessed on February 10, 2015.

Centre national de référence des Papillomavirus humains (CNR HPV), Institut Pasteur. Available online: http://www.pasteur.fr/fr/sante/info-hp. Accessed on February 2, 2015.

Haut Conseil de la santé publique (HCSP). 2012 vaccination schedule and recommendations from the « Haut Conseil de la santé publique » in France. Bull Epidémiol Hebd. 2012;14–15. Available online: http://www.invs.sante.fr/Publications-et-outils/BEH-Bulletin-epidemiologique-hebdomadaire/Archives/2012/BEH-n-14-15-2012. Accessed on February 17, 2015.

Haut Conseil de la santé publique (HCSP). Infections à HPV des jeunes filles: révision de l’âge de vaccination; 2012. Available online: http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=302. Accessed on February 2, 2015.

Haut Conseil de la santé publique (HCSP). Avis relatif au vaccin Gardasil® et à la stratégie de prévention globale des cancers du col de l’utérus. 21^st October 2011. Available online: http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=454. Accessed on February 10, 2015.

Chardon O, Guignon N. La santé des adolescents scolarisés en classe de troisième. Etudes et résultats. DREES; 2014;865. Available online: http://www.drees.sante.gouv.fr/la-sante-des-adolescents-scolarises-en-classe-de-troisieme,11247.html. Accessed on February 21, 2015.

Antona D, Fonteneau L, Lévy Bruhl D, Guignon N, De Peretti C, Niel X, et al. Vaccination coverage of children and adolescents in France: results of school-based surveys, 2001–2004. Bull Epidémiol Hebd. 2007;7. Available online: http://www.invs.sante.fr/beh/2007/06/. Accessed on February 24, 2015.

Tuppin P, de Roquefeuil L, Weill A, Ricordeau P, Merliere Y. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique. 2010;58:286–90.CrossRefPubMed

De Roquefeuil L, Studer A, Neumann A, Meliere Y. The Echantillon généraliste de bénéficiaires: representativeness, scope and limits. Prat Organ Soins. 2009;40(3):213–23.CrossRef

10.

Fonteneau L, Ragot M Guthmann J-P, Lévy-Bruhl D. Use of health care reimbursement data to estimate vaccination coverage in France: example of, hepatitis B, meningitis C and human papillomavirus vaccination. Rev Epidemiol Sante Publique, 2015, 00362-4.

11.

Cohen R, Denis F, Gaudelus J, Lery T, Lepetit H, Martinot A, et al. Immunization coverage: Teenagers are in danger… Status on the occasion of vaccination week. Med Mal Infect. 2012;42:139–40.

12.

Reuss AM, Feig M, Kappelmayer L, Siedler A, Eckmanns T, Poggensee G. Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health. 2010;10:502. Available online: http://www.biomedcentral.com/1471-2458/10/502. Accessed on February 17, 2015.

13.

Kalies H, Redel R, Varga R, Tauscher M, von Kries R. Vaccination coverage in children can be estimated from health insurance data. BMC Public Health. 2008;8:82. Available online: http://www.biomedcentral.com/1471-2458/8/82. Acessed on February 2, 2015.

14.

Venice II Consortium. Vaccination coverage assessment in EU/EEA, 2011. 2012. Available online: http://venice.cineca.org/Final_Vaccination_Coverage_Assesment_Survey_2011_1.pdf. Accessed on February 17, 2015.

15.

Haut Conseil de la santé publique (HCSP). Vaccination contre les infections à papillomavirus humain. HCSP; 2014. Available online: http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=454. Accessed on February 10, 2015.

16.

Calendrier des vaccinations et recommandations vaccinales 2014. INPES; 2014. Available online: http://www.sante.gouv.fr/IMG/pdf/Calendrier_vaccinal_ministere_2.pdf.

Title: The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety
Authors: Laure Fonteneau
Marine Ragot
Isabelle Parent du Châtelet
Jean-Paul Guthmann
Daniel Lévy-Bruhl
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-015-2575-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Anthropometric indices as predictors of hypertension among men and women aged 40–69 years in the Korean population: the Korean Genome and Epidemiology Study

Promoting action control and coping planning to improve hand hygiene

Development and feasibility study of very brief interventions for physical activity in primary care

Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany – results of a database analysis from May 2010 to April 2012

The evidence base of primary research in public health emergency preparedness: a scoping review and stakeholder consultation

Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study